Drug-coated stents did not raise the risk of death and heart attack in patients compared to bare metal stents, according to a study presented at the American Heart Association's annual meeting Sunday. Meanwhile, results of another study that analyzed costs from earlier research comparing stents and angioplasty surgery, found that stents are not cost-effective in patients with chronic chest pain and did not prolong patients' lives.

Related Summaries